Antiviral Activity of Ivermectin Against SARS-CoV-2: An Old-Fashioned Dog with a New Trick-A Literature Review
The coronavirus disease 2019 (COVID-19) pandemic is a major global threat. With no effective antiviral drugs, the repurposing of many currently available drugs has been considered. One such drug is ivermectin, an FDA-approved antiparasitic agent that has been shown to exhibit antiviral activity agai...
Saved in:
Main Authors: | Mudatsir Mudatsir (Author), Amanda Yufika (Author), Firzan Nainu (Author), Andri Frediansyah (Author), Dewi Megawati (Author), Agung Pranata (Author), Wilda Mahdani (Author), Ichsan Ichsan (Author), Kuldeep Dhama (Author), Harapan Harapan (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Remdesivir and its antiviral activity against COVID-19: A systematic review
by: Andri Frediansyah, et al.
Published: (2021) -
Antivirals for COVID-19: A critical review
by: Andri Frediansyah, et al.
Published: (2021) -
Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia
by: Harapan Harapan, et al.
Published: (2020) -
SARS-CoV-2 reinfection and implications for vaccine development
by: Firzan Nainu, et al.
Published: (2020) -
Coronavirus disease 2019 (COVID-19): A literature review
by: Harapan Harapan, et al.
Published: (2020)